Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJarvis Securities Regulatory News (JIM)

Share Price Information for Jarvis Securities (JIM)

Share Price is delayed by 15 minutes
Get Live Data
9.00    0.00 (0.00%)
Bid:
8.00
Ask:
10.00
Spread: 2.00 (25.00%)
Market Cap: £4.03m
JIM Live PriceLast checked at - London Stock Exchange

Intraday Jarvis Securities Share Chart

Update on JIML

5 May 2026 07:00

RNS Number : 9084C
Jarvis Securities plc
05 May 2026
 

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Jarvis Securities plc

("Jarvis" or the "Company" and with its subsidiaries the "Group")

Update on JIML

On 7 July 2025 Jarvis announced (the "Announcement") that its wholly owned subsidiary Jarvis Investment Management Limited ("JIML") has sold its retail execution only brokerage business, (the "Transaction"). In order to deliver optimal value for shareholders, the Company has engaged S&W Partners LLP to explore the possibility of a sale of JIML. (the "Potential Disposal"). The Potential Disposal will be subject to conditions set out below and there can be no certainty as to the timing of the Potential Disposal or that it will occur at all.

After the Transaction, the termination of the Model B clearing and settlement services and the wind down of the associated operations (as further detailed in the Announcement) the assets presently remaining in JIML (which has permissions to undertake regulated activities and hold client assets) are:

i. approximately 1,800 clients with assets under administration of circa £44 million (including circa £7 million of potentially illiquid and/or non-returnable client assets), although this is declining as assets are withdrawn;

ii. the right to receive any deferred consideration due from the Transaction;

iii. any remaining cash balances; and 

iv. the group's intellectual property (which includes the "X-O" and "Sharedeal Active" trademarks).

 

It should be noted that any proposed sale of JIML's shares and any associated change of control would be subject to, the FCA's consent. 

Further updates will be provided in due course.

Steve Middleton, Non-executive Director of Jarvis Securities Plc, has approved this announcement and authorised its release.

Enquiries

Jarvis - C/O S&W Partners LLP - 0204 617 55 00 (Phil Hemming (Phil.hemming@swgroup.com) / Christopher Samson (Samson.christopher@swgroup.com))

 Zeus Capital (Nominated Adviser) - 020 3829 5000 (Katy Mitchell / Liv Highton)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDAKQBDFBKDAPK
Date   Source Headline
10th Aug 20237:00 amRNSDividend Declaration & Trading Update
13th Jul 20237:00 amRNSHalf-year Report
4th Jul 20232:57 pmRNSCompany Update
3rd Jul 20235:06 pmRNSHolding(s) in Company
3rd Jul 20235:04 pmRNSHolding(s) in Company
3rd Jul 20235:00 pmRNSHolding(s) in Company
3rd Jul 20234:59 pmRNSHolding(s) in Company
16th Jun 20238:59 amRNSHolding(s) in Company
16th Jun 20238:57 amRNSHolding(s) in Company
16th Jun 20238:54 amRNSHolding(s) in Company
11th May 20232:04 pmRNSDividend Declaration
20th Apr 20231:24 pmRNSResult of AGM
31st Mar 20237:00 amRNSCompany Update
9th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20232:05 pmRNSSecond Price Monitoring Extn
9th Mar 20232:00 pmRNSPrice Monitoring Extension
9th Mar 20237:00 amRNSResults for year ended 31 December 2022
8th Feb 20233:20 pmRNSDividend Declaration
10th Nov 20222:01 pmRNSDividend Declaration
13th Oct 20227:00 amRNSDirector/PDMR Shareholding
11th Oct 20225:11 pmRNSDirector/PDMR Shareholding
20th Sep 20229:05 amRNSSecond Price Monitoring Extn
20th Sep 20229:00 amRNSPrice Monitoring Extension
16th Sep 20222:39 pmRNSCompany Update
9th Aug 20223:15 pmRNSDividend Declaration
14th Jul 20227:00 amRNSHalf-year report
10th May 20223:36 pmRNSDividend Declaration
21st Apr 202211:30 amRNSResult of AGM
10th Mar 20227:00 amRNSResults for year ended 31 December 2021
15th Feb 20221:54 pmRNSDividend Declaration
15th Feb 20221:13 pmRNSDividend Declaration
9th Nov 20211:43 pmRNSDividend Declaration
10th Aug 20211:50 pmRNSDividend Declaration
16th Jul 202112:24 pmRNSShare Premium Cancellation & Dividend Declaration
15th Jul 20217:00 amRNSHalf-year Report
29th Jun 202112:27 pmRNSCancellation of Share Premium - Court approved
23rd Jun 20217:00 amRNSCancellation of Share Premium - Update
11th Jun 20211:03 pmRNSCancellation of Share Premium Update
12th May 20217:00 amRNSDividend Declaration
4th May 202112:45 pmRNSResult of General Meeting
26th Apr 20212:49 pmRNSNotice regarding COVID-19 and the General Meeting
22nd Apr 202110:36 amRNSResult of AGM
8th Apr 20217:00 amRNSResult of PrimaryBid Offer
7th Apr 20214:54 pmRNSPrimaryBid Offer, Notice of GM & Capital Reduction
30th Mar 20217:00 amRNSBoard Changes
19th Mar 20212:30 pmRNSTransaction in Own Shares
11th Mar 20217:00 amRNSResults for year ended 31 December 2020
16th Feb 202112:11 pmRNSDividend Declaration
3rd Feb 20211:31 pmRNSHolding(s) in Company
11th Dec 202010:19 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.